SAGER ERICH 4
4 · Raptor Pharmaceutical Corp · Filed May 21, 2013
Insider Transaction Report
Form 4
SAGER ERICH
Director
Transactions
- Exercise of In-Money
Common Stock Warrants (right to buy)
2013-05-17−25,284→ 0 totalExercise: $2.36From: 2013-05-17Exp: 2013-05-21→ Common Stock (25,284 underlying) - Exercise of In-Money
Common Stock Warrants (right to buy)
2013-05-17−14,369→ 0 totalExercise: $2.36From: 2013-05-17Exp: 2013-06-27→ Common Stock (14,369 underlying) - Other
Common Stock Warrants (right to buy)
2013-05-17+25,284→ 25,284 totalExercise: $2.36From: 2013-05-17Exp: 2013-05-21→ Common Stock (25,284 underlying) - Exercise of In-Money
Common Stock
2013-05-17$2.36/sh+39,653$93,581→ 147,727 total - Other
Common Stock Warrants (right to buy)
2013-05-17+14,369→ 14,369 totalExercise: $2.36From: 2013-05-17Exp: 2013-06-27→ Common Stock (14,369 underlying)
Footnotes (2)
- [F1]Exercise of a common stock warrant distributed to Mr. Sager on May 17, 2013 by Aran Asset Management ITF Limetree Capital.
- [F2]Distribution of a common stock warrant to Mr. Sager on May 17, 2013 by Aran Asset Management ITF Limetree Capital. Mr. Sager was a Partner of Limetree Capital prior to its liquidation in 2012.